Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

SynRx Raises $14 Million to Develop Drugs for Solid Tumor Cancers with DNA Damage

publication date: Nov 17, 2022

SynRx Therapeutics, a Hangzhou biopharma startup, closed a $14 million Series Pre-A financing round to advance its portfolio of five oncology candidates. The company focuses on solid tumor cancers with homologous recombination deficiency (HRD) – tumors that are unable to repair double-strand breaks (DSBs) in DNA, a condition that ultimately causes cancer. The company’s technology is based on original research from the lab of Founder and Chairman Xiaochun Yu. The round’s investors include Lapam Capital, Fenghua Venture, Westlake Innovation Capital and Long Yield Venture Capital. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here